Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina. more
Time Frame | LH | Sector | S&P500 |
---|---|---|---|
1-Week Return | -1.91% | -1.95% | 0.69% |
1-Month Return | -3.25% | -3.36% | 1.53% |
3-Month Return | 4.01% | -6.93% | 11.27% |
6-Month Return | 20.46% | -1.83% | 13.49% |
1-Year Return | 9.18% | 8.53% | 31.62% |
3-Year Return | -2.57% | 7.58% | 30.33% |
5-Year Return | 62.48% | 44.7% | 93.83% |
10-Year Return | 162.16% | 103.96% | 195.13% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 11.55B | 13.98B | 16.12B | 14.88B | 12.16B | [{"date":"2019-12-31","value":71.68,"profit":true},{"date":"2020-12-31","value":86.71,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":92.28,"profit":true},{"date":"2023-12-31","value":75.44,"profit":true}] |
Cost of Revenue | 8.30B | 9.03B | 10.50B | 10.49B | 8.80B | [{"date":"2019-12-31","value":79.1,"profit":true},{"date":"2020-12-31","value":85.99,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.95,"profit":true},{"date":"2023-12-31","value":83.81,"profit":true}] |
Gross Profit | 3.25B | 4.95B | 5.62B | 4.39B | 3.36B | [{"date":"2019-12-31","value":57.83,"profit":true},{"date":"2020-12-31","value":88.06,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":77.97,"profit":true},{"date":"2023-12-31","value":59.83,"profit":true}] |
Gross Margin | 28.15% | 35.43% | 34.89% | 29.48% | 27.67% | [{"date":"2019-12-31","value":79.44,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":98.47,"profit":true},{"date":"2022-12-31","value":83.19,"profit":true},{"date":"2023-12-31","value":78.09,"profit":true}] |
Operating Expenses | 1.87B | 2.00B | 2.32B | 2.26B | 2.02B | [{"date":"2019-12-31","value":80.45,"profit":true},{"date":"2020-12-31","value":86.35,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.17,"profit":true},{"date":"2023-12-31","value":87.07,"profit":true}] |
Operating Income | 1.33B | 2.45B | 3.26B | 1.77B | 725.60M | [{"date":"2019-12-31","value":40.81,"profit":true},{"date":"2020-12-31","value":75.02,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":54.42,"profit":true},{"date":"2023-12-31","value":22.26,"profit":true}] |
Total Non-Operating Income/Expense | (466.00M) | (433.70M) | (345.00M) | (379.40M) | (357.10M) | [{"date":"2019-12-31","value":-46600000000,"profit":false},{"date":"2020-12-31","value":-43370000000,"profit":false},{"date":"2021-12-31","value":-34500000000,"profit":false},{"date":"2022-12-31","value":-37940000000,"profit":false},{"date":"2023-12-31","value":-35710000000,"profit":false}] |
Pre-Tax Income | 1.10B | 2.22B | 3.13B | 1.58B | 568.90M | [{"date":"2019-12-31","value":35.34,"profit":true},{"date":"2020-12-31","value":70.97,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":50.62,"profit":true},{"date":"2023-12-31","value":18.2,"profit":true}] |
Income Taxes | 280.00M | 662.10M | 747.10M | 302.00M | 188.50M | [{"date":"2019-12-31","value":37.48,"profit":true},{"date":"2020-12-31","value":88.62,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":40.42,"profit":true},{"date":"2023-12-31","value":25.23,"profit":true}] |
Income After Taxes | 824.90M | 1.56B | 2.38B | 1.28B | 380.40M | [{"date":"2019-12-31","value":34.67,"profit":true},{"date":"2020-12-31","value":65.43,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":53.82,"profit":true},{"date":"2023-12-31","value":15.99,"profit":true}] |
Income From Continuous Operations | 824.90M | (900.00K) | 2.38B | 1.28B | 861.40M | [{"date":"2019-12-31","value":34.67,"profit":true},{"date":"2020-12-31","value":-0.04,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":53.82,"profit":true},{"date":"2023-12-31","value":36.2,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 823.80M | 1.56B | 2.38B | 1.28B | 418.00M | [{"date":"2019-12-31","value":34.65,"profit":true},{"date":"2020-12-31","value":65.46,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":53.8,"profit":true},{"date":"2023-12-31","value":17.58,"profit":true}] |
EPS (Diluted) | 11.31 | 23.91 | 28.51 | 19.88 | 14.30 | [{"date":"2019-12-31","value":39.67,"profit":true},{"date":"2020-12-31","value":83.87,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":69.73,"profit":true},{"date":"2023-12-31","value":50.16,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
LH | |
---|---|
Cash Ratio | 0.44 |
Current Ratio | 1.44 |
Quick Ratio | 1.30 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
LH | |
---|---|
ROA (LTM) | 3.96% |
ROE (LTM) | 5.43% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
LH | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.56 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.44 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
LH | |
---|---|
Trailing PE | 44.70 |
Forward PE | 14.62 |
P/S (TTM) | 1.55 |
P/B | 2.38 |
Price/FCF | 122 |
EV/R | 2.02 |
EV/Ebitda | 17.80 |
PEG | 0.50 |
Laboratory Corporation of America Holdings (LH) share price today is $236
Yes, Indians can buy shares of Laboratory Corporation of America Holdings (LH) on Vested. To buy Laboratory Corporation of America Holdings from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Laboratory Corporation of America Holdings (LH) via the Vested app. You can start investing in Laboratory Corporation of America Holdings (LH) with a minimum investment of $1.
You can invest in shares of Laboratory Corporation of America Holdings (LH) via Vested in three simple steps:
The 52-week high price of Laboratory Corporation of America Holdings (LH) is $303.77. The 52-week low price of Laboratory Corporation of America Holdings (LH) is $169.07.
The price-to-earnings (P/E) ratio of Laboratory Corporation of America Holdings (LH) is 44.0473
The price-to-book (P/B) ratio of Laboratory Corporation of America Holdings (LH) is 2.38
The dividend yield of Laboratory Corporation of America Holdings (LH) is 1.24%
The market capitalization of Laboratory Corporation of America Holdings (LH) is $19.45B
The stock symbol (or ticker) of Laboratory Corporation of America Holdings is LH